RxSight, Inc.
Nasdaq · Ophthalmic Goods
Company Overview
A concise company profile alongside the latest public filing activity.
RxSight develops and sells the Light Adjustable Lens, an intraocular lens implanted after cataract surgery whose optical power can be customized and refined after implantation using its Light Delivery Device, along with related lenses and services for cataract surgeons.
Company profile sourced from SEC filings.
Corporate Insider Trades
Open-market purchases and sales by directors, officers, and other company insiders.
| Insider | Type | Value | Shares / Price | Date |
|---|---|---|---|---|
| Wilterding MarkChief Financial Officer | Sell | $54K | 7,765at $6.96 | Sep 2, 2026 |
| Kurtz Ronald M MDChief Medical Officer | Sell | $35K | 5,100at $6.96 | Sep 2, 2026 |
| Goldshleger IlyaChief Operating Officer | Sell | $14K | 2,041at $6.96 | Sep 2, 2026 |
| Weinberg EricSee remarks | Sell | $14K | 2,041at $6.96 | Sep 2, 2026 |
Source: SEC EDGAR Form 4 filings
Congressional Trades
Recent disclosures by members of the U.S. House and Senate.
Source: Senate eFD and House Clerk STOCK Act disclosures
Get notable RXST activity by email
Free alerts for the insider and congressional trades worth watching.
For informational purposes only, not investment advice. Filings can be delayed, corrected, or amended. Trading activity alone does not predict future performance.